During the past decade, ViRx Inc conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ViRx Inc" #1 sponsor was "Parke-Davis" with 2 trials, followed by "Agouron Pharmaceuticals" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored, "Harbor Therapeutics" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ViRx Inc" #1 collaborator was "Trimeris" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "ViRx Inc" are "HIV Infections" (8 trials), "HIV Seronegativity" (1 trials) and "Herpes Simplex" (1 trials). Many other conditions were trialed in "ViRx Inc" in a lesser frequency.

Most popular intervention types in "ViRx Inc" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "CI-1012" (2 trials), "Abacavir sulfate" (1 trials), "Acyclovir" (1 trials), "Adefovir dipivoxil" (1 trials) and "Amprenavir" (1 trials). Other intervention names were less common.

The vast majority of trials in "ViRx Inc" are 8 trials for "All" genders.

Currently, there are NaN active trials in "ViRx Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in ViRx Inc, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ViRx Inc, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".